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ABSTRACT
Objectives: Vulvodynia diagnosis is based on medical history and physical examination. The study is aimed to evaluate 
the clinical usefulness of a pelvic floor physical examination (VAMP protocol) for vulvodynia diagnosis, applied during 
gynecological examination, proposed as educational and diagnostic tool. 
Material and methods: Pelvic physical examinations were performed for 650 non-pregnant female patients. A study 
group of 449 cases met the vulvodynia diagnostic criteria (120 with provoked, 104 with spontaneous, and 121 with mixed 
subtype) and were compared with those of 201 healthy individuals. Four anatomical regions were examined: the vulva 
(V) and anus (A) with a cotton swab, the internal pelvic muscles (M) with a digital examination of the levator ani, and the 
paraurethral (P) area with digital pressure. Only the maximum pain score for a given area was recorded, using a Numerical 
Rating Scale. The four anatomical regions were recorded under the VAMP acronym.
Results: Differences in mean scores VAMP protocol were statistically between vulvodynia and comparison group for 
V = 6.48 vs 0.98; M = 6.29 vs 1.05; and P = 6.89 vs 1.33, with exception of A = 0.03 vs 0.08. Patient age, weight, way of deliv-
ery, other concomitant diseases (e.g., dysuria, anal and bowel symptoms), vulvodynia subtype, and pain duration did not 
influence VAMP scores in patients with vulvodynia and comparison group. 
Conclusions: Pelvic examination according to VAPM protocol can be applied in vulvar pain patients for diagnostic 
purposes. Besides of vulvodynia symptoms any other analyzed variables did not influence on scores of VAMP protocols.  
We found that cut-off score ≥ 3 even in one of V, M or P component of VAMP protocol can be considered as diagnostic 
criterium for vulvodynia. Component A (anus area) was not useful for vulvodynia diagnosis.
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INTRODUCTION 
Vulvodynia (Vd) is a form of chronic vulvar pain and 
other discomfort that persists for more than three months 
in the absence of any evident vulvovaginal pathology, in ac-
cordance with the criteria outlined in the recent consensus 
statement [1]. Chronic vulvar pain is most commonly de-
scribed as pain perceived superficially in areas of the vulva, 
anus, perineum, or vagina [2–4]. The International Society for 
the Study of Vulvovaginal Disease (ISSVD) described Vd as 
vulvar discomfort, reported as pain, irritation, pruritus, sick-
ness, and oversensitivity, which are often overlooked [1, 2]. 
Remission and relapse are common, although consecutive 
recurrences can present varying symptoms that can be 
confusing for the patient and healthcare practitioners. 
The classification of vulvodynia is based on the site 
of the pain; whether it is generalized, localized, or mixed; 
whether it is provoked (pain on touching, pressure, vaginal 
penetration) or spontaneous (for no apparent reason), or 
mixed; whether the onset is primary or secondary; and the 
temporal pattern (whether the pain is intermittent, persis-
tent, constant, immediate, or delayed) [1, 2] .
In the general population, Vd affects 8.3–16% of adult 
women [2, 5, 6], and the most prevalent form is provoked 
Vd, which presents in 12% of women and can cause super-
ficial dyspareunia. Spontaneous Vd is less common (6–7% 
of Vd) [5]. 
Vd is classified as a functional pain syndrome that is 
mediated by pelvic floor muscles (PFM) dysfunction in the 
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form of an overactive, hypertonic/non-relaxing muscle state 
that then potentially gives rise to pain [3, 5–11]. Overac-
tive muscles have been suspected in 80–90% of patients 
with Vd and provide the indication for pelvic manual and 
general physiotherapy [12, 13]. A psychologic predisposi-
tion to chronic functional pain syndromes has been previ-
ously identified [14], and emotional stress can contribute to 
myofascial disorders. The manual palpation of muscles and 
points of tenderness (trigger points) provides an effective 
real-time method for identifying the source of pain in Vd 
[9, 15–17], although there is no standardized protocol for 
clinical practice [18]. From the literature, several key points 
should be maintained for pelvic physical exam requirements 
in patients with chronic pain [18]. The Numeric Rating Scale 
(NRS) is a preferred scale for patient self-perceived pain 
ratings [9, 19–21], graded during the test using a numeric 
scale of 0 to 10, with 0 representing “no pain at all” and 
10 suggesting “the worst possible pain”. 
Diagnosis of Vd is based on medical history (reported 
symptoms, duration of pain or other discomfort), vulvar ex-
amination with exclusion of other specific disorders as a cause 
of pain, like identified infection (e.g., candidiasis, herpes), 
inflammation (e.g., lichen simplex chronicus, sclerosus, li-
chen planus), neoplasia (eg, Paget disease, vulvar cancer), or 
a neurologic disorder (e.g., herpes neuralgia) [1]. Consecutive 
step in Vd diagnosis is composed of hymenal remnant base 
pain on pressure as a cotton swab testing [9, 15]. Vestibular 
cotton swab test remains PFM referred pain anatomical area, 
what is sufficient for Vd diagnosis [22]. However, examinations 
of additional anatomical areas can give additional, accurate 
insight to increase internal consistency in PFM overactive 
status assessment in Vd women [15–17]. Examination of pelvic 
muscles is recommended but rarely conducted. Currently no 
standardized protocol exists [9, 15, 17, 18].
The Integrated Pain Mapping and Assessment Protocol 
(IMAP) was developed for research purposes as referred pain 
diagnostic maps by Jantos [13, 19], and includes 54 relevant 
and irrelevant, external and internal points of examination. 
Shortened version of IMAP, which focuses on the vulva, anus, 
internal pelvic muscles, and paraurethral regions was elabo-
rated, proposed as the part of gynecological examination, 
recorded as VAMP acronym and evaluated in this study as 
a simplified clinical pain mapping modality for diagnostic 
and educational purposes. The study is aimed to evaluate the 
clinical usefulness of a pelvic floor physical examination (VAMP 
protocol) for vulvodynia diagnosis, applied during gynecologi-
cal examination, proposed as educational and diagnostic tool. 
MATERIAL AND METHODS
The study characteristics were extracted from the medi-
cal records at outpatient clinic for women, with a focus 
on vulvar diseases. The study was approved by the appro-
priate IRB. We included patients with Vd who were seen 
between January 2016 and July 2018. The described diag-
nostic method has been applied as a routine practice at 
the center since 2014. The comparative data was obtained 
from a group of healthy women between February 2019 and 
June 2019. Every patient in both groups were diagnosed by 
the study authors. A total of 650 women were included in 
the study, 449 of who met the diagnostic criteria for Vd, as 
a study group, and 201 women were assigned to the control 
group. The included participants were nonpregnant adults, 
with no serious general diseases and urogenital surgery 
performed previously. 
Vd was diagnosed as idiopathic vulvar pain (raw or 
vague) or other discomfort as burning sensation, stabbing, 
pressure, and pulling pain, also as the pruritus or dryness, 
discomfort, and oversensitivity. The symptoms sustained 
at least for three months, induced by vaginal penetration 
(provoked), without specific trigger (spontaneous) or both 
(mixed Vd subtype) [1, 2]. A general medical and gyneco-
logical history were recorded for every case, and a physical 
exam was carried out. Four anatomical regions were exam-
ined: the vulva (V) and anus (A) with a cotton swab test, 
the internal pelvic muscles (M) with a digital examination 
of the levator ani, and the paraurethral (P) area with digital 
pressure (Fig. 1). In every patient their VAMP scores were 
determined as a part of a gynecological exam, for any visible 
or detectable pathology exclusion. In the litothomy position 
vaginal speculum insertion, for gynecological purposes, was 
permitted to take place before the internal exam (when 
accepted or possible).
For the VAMP protocol, the following steps were fol-
lowed consecutively (as outlined in Fig. 1):
•	 The Numerical Pain Rating Scale (NRS) was explained, 
through which the patients were asked to rate each 
examined point, if painful. 
•	 Verbal consent should be taken after an explanation. 
•	 A cotton swab test was performed by applying gentle 
pressure to five points within the vestibular base of the 
hymenal remnant (following a vestibular clock from the 
two to ten position) using a dry swob. The pressure was 
adjusted to a level tolerated by the patient. Only the 
maximum NRS rating was noted (V).
•	 A similar cotton swab test was then used for two points 
around the anus, with similar pressure as that used for 
the vulva, and the NRS maximum rating was noted (A).
•	 The insertion of one lubricated, gloved index finger, 
for a bimanual transvaginal or rectal examination was 
performed. 
•	 The palmar side of the index finger was rotated back-
ward to palpate the pelvic floor muscles. The finger was 
moved laterally along the length of the rectum, using 
the single sites mid-muscle belly technique, from the 
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inside to the outside on both the right and the left side. 
A bilateral sliding motion was performed, with marked 
pressure applied to the muscles until the patient’s ac-
cepted pain threshold was reached. The maximum NRS 
rating was noted (M) in the medical records. 
•	 For paraurethral area examination, the palmar side of the 
index finger was rotated upward, laterally to the urethra, 
and similarly to the point of urethra detachment from 
the pubic bone. The movement was performed from the 
outside to the inside of the pubis, lengthwise, on both 
the right and left sides. The pressure was increased with 
particular attention to patient pain tolerance, and the 
maximum NRS rating was noted (P).
The physical exam results were recorded under the 
VAMP acronym (e.g., VAMP 3048), which reflects the maxi-
mum NRS ratings in the four areas: vulva, anus, muscles, 
and paraurethra. The pelvic physical examination added 
approximately two minutes to the gynecological exami-
nation. The VAMP scores were evaluated in relation with 
patient age, body weight, and deliveries in both groups, in 
relation to pelvic diaphragm comorbidities and type of pain 
felt by the study group. 
Statistical analyses were performed using Statistica v 9.1, 
provided by Statsoft Polska, with population parameters 
(mean and standard deviation), χ2 test, one-sided t-test, 
Spearman Correlation and Mann-Whitney U test for critical 
value p = 0.05 application. 
RESULTS
Among the 650 women who were included in this 
study, 449 (69.1%) women comprised the Vd group and 
201 (30.9%) comprised the control group. According the 
Vd subtype differentiation [1], half of the Vd cohort suf-
fered from mixed Vd (50.1%, 225 women), followed by 
provoked Vd (26.7%, 120 women) and spontaneous Vd 
(23.2%, 104 women). 
The individuals in the study and the control group dif-
fered slightly in age (34.7 years vs 37.6 years old) and body 
weight (61.3 kg vs 66.0 kg) (Z = –3.256; p < 0.001). 
Differences in the VAMP protocol scores were identi-
fied between the Vd and the control comparisons in fea-
tures V (vulva) (6.48 ± 2.64 vs 0.98 ± 1.96), M (muscles) 
(6.29 ± 2.55 vs 1.05 ± 1.90), and P (paraurethral area) 
(6.89 ± 2.37 vs 1.33 ± 2.17), with p < 0.001 for each of above 
values. The Vd and comparative cohort did not differ in 
the A (anus) item (0.03 ± 0.37 vs 0.08 ± 0.57, respectively, 
p = 0.11). There were also no differences in the VAMP scores 
between the three vulvodynia subtypes (provoked, mixed, 
and spontaneous) (Fig. 2–4). 
Regression analysis showed no differences in the VAMP 
ratings in relation to age, body weight, or cesarean delivery. 
Patients who underwent vaginal deliveries presented with 
Figure 1. VAMP protocol diagram; V — vulva 5 points cotton swab pressure; A — anus 2 points cotton swab pressure; C — clitoris; U — urethra; 
S — sacrum; R — rectum; VAG — vagina; B — bladder; arrows — internal digital examination
Figure 2. VAMP protocol score: vulvar pain (V) in the three 
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lower V scores (Tab. 1), and this was the only significant 
correlation, other than Vd diagnosis, in all of the groups.
On the basis of statistical data, VAMP protocol score 
cut-off (NRS on pressure) was defined according to consecu-
tive features: V, score 2; A, not relevant; M, score 3; and P, 
score 3, which differed between the study and the healthy 
control, comparison group. Based on the ROC curve analysis, 
there were no differences between VAMP features in the 
study cohort (pV-M = 0.959, pV-P = 0.647, pM-P = 0.539).
Women with Vd showed stable P scores (R Spear-
man = 0.074; p = 0.126) that were independent of the 
duration of pain, whereas V scores (R Spearman = 0.136; 
p = 0.005) and M scores (R Spearman = 0.104; p = 0.032) 
increased with persistent symptoms, although the correla-
tion was very weak. 
Type of pain and discomfort were divided in Vd women: 
1, pain without specific description (raw or vague) in 34.5% 
(155 women); 2, burning sensation in 50.1% (225 women); 
3, stabbing, pressure, and pulling pain in 10.9% (49 women); 
4, pruritus in 42.1% (189 women); and 5, dryness, discomfort, 
and oversensitivity in 23.2% (104 women), in the study co-
hort. When compared with the VAMP features, the highest 
V scores (Z = –4.01; p < 0.001), M scores (Z = –3.51; p < 0.001), 
and P scores (Z = –3.66; p < 0.001) were observed in relation 
to pain (description 1). In the remaining symptoms (descrip-
tions 2, 3, 4) VMP scores were insignificant for Vd group 
(range from Z = –0.27 , p = 0.7 to Z = 0.1, p = 0.92). Lower 
M scores (Z = 2.30; p = 0.021) were associated with dryness, 
discomfort, and vulvar oversensitivity (description 5).
No differences in VAMP protocol scores were found in 
relation to pelvic diaphragm symptoms coexisting with Vd 
(Tab. 2).
DISCUSSION
In our study cohort, half of the women with Vd presented 
a mixed (both spontaneous and provoked symptoms) Vd 
subtype, 25% presented provoked, and 25% presented 
spontaneous. This differs from previous reports in the lit-
erature, where provoked Vd has been reported as the most 
prevalent subtype (64.8%), followed by spontaneous (20.3%) 
and mixed Vd (14.9%) [2]. The differences may be attributed 
to the detailed patient history that was taken, as even mild 
Figure 3. VAMP protocol score: muscle pain (M) in the three 
vulvodynia subgroups and the control group
Figure 4. VAMP protocol score: paraurethral area pain (P) in the three 
vulvodynia subgroups and the control group
Table 1. VAMP protocol score correlation with age, body weight, and vaginal and cesarean delivery in the study (Vd) and control group, based 
on the regression analysis
VAMP Feature V M P
Vulvodynia p ≤ 0.001*** p ≤ 0.001 *** p ≤ 0.001 ***
Age p = 0.481 (NS) p = 0.179 (NS) p = 0.689 (NS)
Body weigh p = 0.475 (NS) p = 0.493 (NS) p = 0.256 (NS)
Vaginal delivery p = 0.036 * p = 0.310 (NS) p = 0.256 (NS)
Cesarean delivery p = 0.737 (NS) p = 0.500 (NS) p = 0.968 (NS)
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Table 2. Mann-Whitney U test comparison of VAMP protocol values with comorbidities in the study (Vd) and control group
Symptoms % cohort Nr of woman V  M P 
Vd and dysuria 35.2 158 p = 0.124 (NS) p = 0.660 (NS) p = 0.083 (NS)
Vd and bowel/ anal 
symptoms 42.8 192 p = 0.702 (NS) p = 0.330 (NS) p = 0.218 (NS)
Dysuria in control 13.1 24 p = 0.217 (NS) p = 0.063 (NS) p = 0.098 (NS)
Bowel/anal 
symptoms in control 38.2 76 p = 0.744 (NS) p = 0.107 (NS) p = 0.805 (NS)
Vd — vulvodynia; V — vulva; M — muscles; P — paraurethral area; NS — not significant
recurrent vulvar itch, irritation, or discomfort (e.g., the dry-
ness or oversensitivity found in one fourth of women with 
Vd) were considered as spontaneous symptoms in patients 
with provoked Vd, which satisfied mixed Vd subtype criteria. 
Vague or raw pain symptoms were found in one third of 
the patients with Vd, although different unpleasant vulvar 
sensations (stabbing, pulling, pressure, and irritation) were 
equally found in the study group. The most frequent descrip-
tor of vulvar pain was a burning vulvar sensation (half of the 
women with Vd), followed by vulvar itch (42.1%). Mistakenly, 
these items are often not considered as pain by healthcare 
professionals or the affected patients. Vd diagnostic criteria, 
including history taking and physical (gynecological and 
pelvic) examination, have to be introduced for such patients 
with recurrent vulvar symptoms.
In the process of diagnosing patients with Vd, a few con-
secutive steps have to be undertaken [3, 6, 9, 13], in agreement 
with the study protocol. PFM status examinations were used 
as a diagnostic tool for every patient with Vd and were proven 
useful in distinguishing approximately 80–90% of patients 
who benefit from pelvic manual and general physiotherapy, 
indicated for spontaneous and provoked Vd with PFM dysfunc-
tion [23–25]. The main feature of overactive PFM is pain upon 
touching the vulva (referred pain) and deep muscles upon 
internal (vaginal or rectal) access [15]. Thus far, no physical 
pelvic examinations for pelvic floor myofascial pain syndrome 
assessments have been standardized [18]. Women with prior 
vaginal delivery presented less vestibulum sensitivity on pres-
sure (lower V score in both study and control group). Regard-
ing to vulvar pain, vulvar score (V) and paraurethral pain on 
pressure (P) score were higher in patients with vague, raw pain 
than in those with other pain descriptions. This could be be-
cause certain types of pain per se might be more troublesome 
for patients, and ischemic pain is often described as stabbing, 
burning, heavy, exhausting and results in lower pain thresholds 
that are consistent with peripheral sensitization [26].
Since the IMAP research and publications in 2015 [13, 19], 
where three maps were proposed for pelvic examinations in 
patients with Vd, a short, modified version (the VAMP proto-
col) has entered clinical practice and research in outpatient 
clinic in diagnosing chronic vulvar pain.
Pain on pressure in VAMP protocol scores were highly 
significant in patients with Vd, according three features: 
V, M and P. This reflects the importance of the three parti-
cular referred trigger points for PFM overactive dysfunction. 
The paraurethral area has to be emphasized as a diagnostic 
anatomical region. 
The anal sphincter area did not experience pain on 
touch, as noticed in previous publications [19], in both 
groups, and thereby was excluded from further statistical 
analyses. Even though the anal cotton swab pressure test 
(A feature in VAMP) was advised by the study authors, to 
concentrate the physician’s attention on that particular area 
and to identify the presence of serious pain sources such 
as anal fissure, lichen simplex or hemorrhoids, especially 
“red flags” such as anal cancer, should not to be overlooked. 
The second reason why the anal area should be tested is to 
objective the overestimation of all VAMP protocol scores due 
to catastrophism or intentional patient’s pain simulation, 
describing as painful area on pressure.
The relevant level of PFM pain on examination (as the 
M feature in the present study) is consistent with other re-
ports that used a cut-off pain score of 3, where pain ≤ 3 was 
considered not clinically significant and pain scores >3 were 
deemed significant [27]. In another publication, pelvic floor 
myofascial pain was determined by transvaginal palpation 
of the bilateral obturator internus and levator ani muscles, 
and, in NRS, it was categorized as none (0), mild (1–3), mod-
erate (4–6), or severe (7–10) for each site [25]. Scores ≥ 3 
(in NRS on examination) on at least one area (V ≥ 3, M ≥ 3, or 
P ≥ 3) confirmed PFM overactive dysfunction in this study. 
The three VAMP examination areas can give a broader over-
active PFM status estimation than the cotton swab test 
alone, to improve reliability, as internal consistency of Vd 
assessment method.
Based on the systematic review of the pelvic physical ex-
amination techniques used to assess pelvic floor myofascial 
pain in women, no specific technique has been standardized 
yet, although the key points have been emphasized [18]. 
Our search for professional pelvic floor muscles dysfunction 
assessments that are commonly used to validate patient-re-
ported pelvic symptoms identified the Pelvic Floor Distress 
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Inventory-20, Pelvic Floor Impact Questionnaire, and Pel-
vic Organ Prolapse Incontinence Sexual Questionnaire are 
considered as recommended materials [11, 16]. The PFM 
status diagnostic methods that are useful for clinical prac-
tice are mostly dedicated to underactive PFM dysfunction 
assessment [11, 16]. Overactive PFM dysfunction estimation 
methods based on physical examination require simplifica-
tion, description for clinical and educational purposes and 
further validation. 
The study limitation concerns the examination according 
to VAMP protocol were performed unblinded without a cali-
brated method of applied pressure, which results from the 
simplification of the diagnosis protocol for clinical practice. 
Another weakness of presented method is subjective char-
acter of results reported by the patients during examination, 
although perceived pain is always considered as subjective. 
The consciousness of women to PFM problems have 
grown with time, along with the demand for healthcare 
professionals in the chronic vulvar pain diagnosis and treat-
ment field. The study provides more detailed information to 
explain vulvodynia management complex issue, method for 
gathering data on sensitive and neglected woman health 
problem. The examination according to VAMP protocol data 
collection is not time consuming, performed as a part of 
bimanual exam of woman with persistent vulvar pain. Ac-
cording to the literature and authors experience, the con-
firmation of an overactive PFM status is crucial for further 
management through which manual therapy and biofeed-
back can be applied [10, 13, 18]. Our study suggests that 
VAMP protocol examination can be useful clinical tool for 
diagnostic and educational purposes. There is a need for 
perspective, multicenter studies to confirm VAMP protocol 
usefulness among physicians dealing with Vd patients. 
CONCLUSIONS
Considering the high prevalence of pelvic floor myofas-
cial pain in Vd patients a routine assessment for pelvic floor 
dysfunction should be followed for all patients who present 
for chronic vulvar and pelvic pain [9, 25]. Pelvic examination 
according to VAPM protocol can be applied in vulvar pain 
patients for diagnostic purposes. Besides vulvodynia symp-
toms, no other analyzed variables had influence on scores of 
VAMP protocol. We found the cut-off score ≥ 3, even in one 
of V, M or P component of VAMP protocol, can be considered 
as diagnostic criterium for Vd with PFM overactivity. Compo-
nent A (anus area) was not useful for Vd diagnosis, although 
remains useful for educational purposes. The VAMP schedule 
is proposed to be a simple exam protocol that consists of 
a cotton swab test of the vestibulum, anus touch (although 
the anus does not experience pain upon applying pressure), 
pelvic floor muscles evaluation by “finger both sides with 
pressure motions” and finally, the application of pressure to 
both sides of the periurethral area. The procedure can be 
performed during a gynecological exam for Vd diagnosis in 
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